These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study. Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343 [TBL] [Abstract][Full Text] [Related]
11. Advances in the management of acute myeloid leukemia in older adult patients. Rogers BB Oncol Nurs Forum; 2010 May; 37(3):E168-79. PubMed ID: 20439202 [TBL] [Abstract][Full Text] [Related]
12. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions? Reikvam H; Kittang AO; Melve G; Mosevoll KA; Bentsen PT; Ersvær E; Gjertsen BT; Bruserud Ø Curr Cancer Drug Targets; 2013 Jan; 13(1):30-47. PubMed ID: 22873213 [TBL] [Abstract][Full Text] [Related]
14. Management of AML: who do we really cure? Liesveld J Leuk Res; 2012 Dec; 36(12):1475-80. PubMed ID: 22938830 [TBL] [Abstract][Full Text] [Related]
15. Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms. Abruzzese E; Niscola P Expert Rev Hematol; 2020 Dec; 13(12):1349-1359. PubMed ID: 33226274 [No Abstract] [Full Text] [Related]
16. [Recent progress in the treatment of acute leukemia]. Kimura Y Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700 [TBL] [Abstract][Full Text] [Related]
17. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH; Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179 [TBL] [Abstract][Full Text] [Related]
18. Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG). Wedding U; Bokemeyer C; Meran JG; ; ; Onkologie; 2004 Feb; 27(1):72-82. PubMed ID: 15007253 [TBL] [Abstract][Full Text] [Related]
19. What is the optimal induction strategy for older patients? Estey E Best Pract Res Clin Haematol; 2011 Dec; 24(4):515-22. PubMed ID: 22127314 [TBL] [Abstract][Full Text] [Related]
20. A critical review of which children with acute myeloid leukaemia need stem cell procedures. Hasle H Br J Haematol; 2014 Jul; 166(1):23-33. PubMed ID: 24749666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]